Fanzhi Medicine
Beijing · Founded 2016
About Fanzhi Medicine
Fanzhi Medicine provides instruments, diagnostic reagents, Internet remote diagnosis and treatment products, and services, encourages advanced nucleic acid diagnostic technology to enter the primary medical system, benefits the general public, and establishes an internationally advanced brand of rapid diagnosis and treatment of major diseases.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $29.4M
- Funding stage: Late Stage Venture
- Last round: Series D (Aug 2025)
- Website: fgbiomed.com
- Phone: +86 400-002-2772
Industries & Categories
Biopharma, Health Diagnostics, Pharmaceutical
Canonical: https://fsome.com/organization/fanzhi-medicine-132223 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.